MARC details
| 000 -LEADER |
| fixed length control field |
01630pam a2200397 i 4500 |
| 001 - CONTROL NUMBER |
| control field |
9916374113406676 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
TH-BaNU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20220909114827.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
211104s2014 caua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
| LC control number |
2013043146 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780123820303 (alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0123820308 (alk. paper) |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
YDXCP |
| -- |
IMN |
| -- |
TH-BaNU |
| 041 0# - LANGUAGE CODE |
| Language code of text/sound track or separate title |
eng |
| 042 ## - AUTHENTICATION CODE |
| Authentication code |
pcc |
| -- |
nlmcopyc |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QV 744 |
| Item number |
S55 2014 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Silverman, Richard B., |
| Relator term |
author. |
| 245 14 - TITLE STATEMENT |
| Title |
The organic chemistry of drug design and drug action / |
| Statement of responsibility, etc. |
Richard B. Silverman, Mark W. Holladay. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
Third edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
San Diego, CA : |
| Name of producer, publisher, distributor, manufacturer |
Elsevier/Academic Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2014 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xviii, 517 pages : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
29 cm |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
volume |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Chemistry, Pharmaceutical |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D002626 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Chemistry, Organic |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D002625 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Drug Design |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D015195 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Pharmacokinetics |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D010599 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Holladay, Mark W., |
| Relator term |
author. |
| 850 ## - HOLDING INSTITUTION |
| Holding institution |
Kuakarun Nursing Library |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
National Library of Medicine Classification |
| Koha item type |
General Book |
| Koha issues (borrowed), all copies |
1 |
| 998 ## - STAFF NAME (NMU) |
| Cataloger |
nuch |